No Picture
News

Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO: SAN DIEGO, Jan. 31, 2022 /PRNewswire/ — Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage oncology company, developing new precision medicine treatment options for cancer patients in indications with the greatest unmet medical need including KRAS-mutated colorectal cancer, pancreatic cancer, and castrate-resistant prostate cancer, today announced that on January… Click here to view original post… […]

No Picture
News

Denovo Biopharma LLC Announces FDA Approval of IND to Initiate First Biomarker-Guided Global CNS Clinical Trial for Treatment-Resistant Depression (TRD)

SAN DIEGO: SAN DIEGO, Jan. 31, 2022 /PRNewswire/ — Denovo Biopharma LLC ("Denovo"), a pioneer in applying precision medicine to the development of innovative therapies, today announced that the FDA has authorized the company’s investigational new drug (IND) application of DB104 (liafensine) for treatment-resistant depression (TRD) to proceed, which enables… Click here to view original post… […]

No Picture
News

NuVasive Appoints Andrew C. Morton as Chief Human Resources Officer

SAN DIEGO: SAN DIEGO, Jan. 31, 2022 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the appointment of Andrew (Drew) C. Morton as senior vice president and chief human resources officer (CHRO) effective… Click here to view original post… […]

No Picture
News

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022

SAN DIEGO: SAN DIEGO, Jan. 31, 2022 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its third quarter fiscal year 2022, ended December 31, 2021, at 4:15 p.m. EST on… Click here to view original post… […]

No Picture
News

REGENXBIO Announces Presentations at the 18th Annual WORLDSymposium™ 2022

ROCKVILLE, Md.: ROCKVILLE, Md., Jan. 31, 2022 /PRNewswire/ — Interim data from Phase I/II trials of RGX-121 for the treatment of MPS II and RGX-111 for the treatment of MPS I to be presentedREGENXBIO Inc. (Nasdaq: RGNX) today announced that five oral and seven poster presentations will be presented at… Click here to view original post… […]

No Picture
News

UK biotechs smash 2020 investment records, surpassing San Diego in VC and IPO raises

As stocks tumble amid a vicious biotech bear market, the UK has found something to celebrate: Last year, UK-based biotechs smashed the investment records they set in 2020, raising a mammoth $6.04 billion (£4.5 billion) in 2021 and surpassing San Diego in terms of venture and IPO funding. That’s a… Click here to view original post… […]

No Picture
News

Ablexis and AlivaMab Discovery Services Announce Agreements with Almirall to Accelerate Antibody Drug Discovery and Development

SAN DIEGO, Calif. & BARCELONA, Spain–(BUSINESS WIRE)–AlivaMab Discovery Sevices and Ablexis, have partnered with Almirall to discover new therapeutic antibodies for severe dermatological conditions. Click here to view original post… […]

No Picture
Uncategorized

Research Regulatory Specialist – Genomics – Rady Children’s Hospital-San Diego – San Diego, CA

Schedule: Days, 8-hour shifts. The Regulatory Specialist has a good working knowledge of clinical regulatory requirements and IRB requirements and processes.From Rady Children’s Hospital San Diego – Sat, 29 Jan 2022 19:51:36 GMT – View […]

No Picture
News

A Map for the Sense of Smell

Our sensory systems provide us with immediate information about the world around us. Researchers have created the first sensory map for smell. The map details how the fruit fly’s olfactory receptor neurons, the components that sense smell, are organized within the insect’s sensory hairs. Click here to view original post… […]

No Picture
Uncategorized

Senior Scientist, Translational Bioinformatics, Late Development Oncology – Bristol Myers Squibb – San Diego, CA

In this role, the applicant will apply cutting-edge bioinformatics, statistics, and data-mining methods to assist statistical interpretation and hypothesis…From Bristol-Myers Squibb – Fri, 28 Jan 2022 20:22:12 GMT – View all San Diego, CA jobsClick […]

No Picture
San Diego Biotech Jobs

Senior Scientist, Molecular AI, Predictive Sciences – Bristol Myers Squibb – San Diego, CA

This individual will work as part of a multidisciplinary team – which includes computational, biology, and chemistry researchers – to develop predictive models…From Bristol-Myers Squibb – Fri, 28 Jan 2022 18:51:44 GMT – View all San Diego, CA jobs […]

No Picture
News

A Map for the Sense of Smell

Our sensory systems provide us with immediate information about the world around us. Researchers have created the first sensory map for smell. The map details how the fruit fly’s olfactory receptor neurons, the … […]

No Picture
News

As pockets fill with cash, Maravai spends $240M to ensure pure mRNA production

A San Diego-based life sciences company is taking over a longtime supplier and California neighbor to boost the purity of its nucleotides and improve the manufacturing process of mRNA, as the boom calls for more demand. Maravai LifeSciences acquired MyChem for $240 million cash in a… Click here to view original post… […]

No Picture
News

Salk Institute Trustees elect Marna C. Whittington as Board chair

LA JOLLA—Marna C. Whittington, the former CEO of Allianz Global Investors Capital, was elected as chair of the Salk Institute’s Board of Trustees on November 12, 2021. Whittington replaces Daniel C. Lewis, former president of the global commercial management-consulting firm Booz Allen Hamilton. The post Salk Institute Trustees… Click here to view original post… […]

No Picture
News

Novoron Bioscience Awarded NIH Grant for Research Into Alzheimer’s Disease

SAN DIEGO: SAN DIEGO, Jan. 28, 2022 /PRNewswire/ — Novoron Bioscience, a San Diego-based biotechnology company developing first-in-class therapies to reverse central nervous system (CNS) damage, announced today that they have been awarded an NIA/NIH grant to advance their work into Alzheimer’s Disease (AD), chronic traumatic encephalopathy (CTE), and other… Click here to view original post… […]

No Picture
News

Blueprint Medicines gets more ducks in a row before CEO transition; Paul Stoffels has his work cut out for him at Gilead’s crumbling partner

Philina Lee ? When Jeff Albers announced he would no longer be CEO of Blueprint Medicines, the leadership carousel at the Aykakit maker had yet to wind down. Yes, Kate Haviland is next in line to replace Albers in April and Christina Rossi will succeed… Click here to view original post… […]

No Picture
Uncategorized

Process Development and Manufacturing Research Associate/Scientist-KOKI DAR-T (5 openings) – Sorrento Therapeutics – San Diego, CA

The selected candidate will direct the development of novel technologies and processes for generating gene modified T cells from donor T-cells, with the goal of…From Sorrento Therapeutics – Fri, 28 Jan 2022 09:32:10 GMT – […]

No Picture
News

The 7th Annual Emerald Conference Produced by MJBizScience Returns to San Diego

DENVER–(BUSINESS WIRE)–The Emerald Conference, curated by the Emerald Conference’s Scientific Committee, returns in person, February 27-March 1, 2022 to the Loews Coronado Bay Resort in San Diego. The Emerald Conference is the original, longest running interdisciplinary cannabis science event. Acquired by MJBiz in early 2020, the 2-day conference has become… Click here to view original post… […]